InfectRisk

Flu season in Denmark

Current flu, COVID-19 and RSV activity in Denmark, based on ECDC ERVISS weekly data from Statens Serum Institut (SSI). Rescaled into a consultation-equivalent signal for a qualitative low / moderate / high classification.

Influenza: Low

Low

No. Flu activity in Denmark is currently low and falling (as of 16 Aug 2026).

Data window: Week 33 · Aug 10 – Aug 16 · Source: ECDC (weekly) · Source on seasonal break, next data from week 40

Get one free alert when the wave turns in Denmark

We write exactly once: the moment the level goes up. No account, no newsletter. We store your address and the country, nothing else. Every mail has a one click unsubscribe. Privacy

View the last 8 weeks

In week 33 of 2026, Influenza activity in Denmark is classified as low.

The reported value is 100% lower than in week 32.

Across the last 8 reported weeks the highest reading was week 32; the level was low in 8 of them.

The last 8 reported weeks

WeekRelativeLevelvs prior week
Week 330Low−100%
Week 32100Low+302%
Week 3125Low−37%
Week 3040Low
Week 290Low
Week 280Low
Week 270Low
Week 260Low

Relative means the highest of these weekly values is set to 100. Exact incidence rates are in the app.

Is flu going around right now?

Know when it affects you.

This page shows your country. The app shows you.

  • Exact numbers and incidence rates, not just low, moderate, high
  • Your personal risk by age and region
  • A push alert when the wave tips in your region
  • 35 countries and a home-screen widget
Download on the

Current activity

12-week trend · Influenza · Relative development · ECDC ERVISS
Week 22Week 25Week 28Week 30Week 33
  • InfluenzaLow
    Trend: falling · Week 33
  • COVID-19Low
    Trend: falling · Week 33
  • RSVLow
    Trend: stable · Week 33

What this means

In week 33 of 2026, activity of influenza (seasonal flu) in Denmark is low. The trend, derived from clinical surveillance, is falling. Over a four-week comparison, a clear decline is visible.

Data, context and methodology

The current picture for Denmark is built on the European Respiratory Virus Surveillance Summary (ERVISS), published weekly by the European Centre for Disease Prevention and Control (ECDC). Statens Serum Institut (SSI) is the national public-health authority that feeds ERVISS with sentinel primary care and virology data. Denmark combines sentinel primary-care surveillance with wastewater monitoring and genomic sequencing, so the ERVISS signal for Denmark is especially well-triangulated.

ECDC ERVISS

ERVISS is ECDC's weekly pan-European surveillance summary for influenza, SARS-CoV-2 and RSV. National authorities, in Denmark's case Statens Serum Institut (SSI), submit harmonised indicators every week, which ECDC publishes in a standardised dataset on Thursdays. Using ERVISS rather than each country's native portal ensures cross-country comparability.

ILI / ARI consultation rates and positivity

Statens Serum Institut (SSI) operates a sentinel network of general practices that report weekly rates of patients consulting for influenza-like illness (ILI) or acute respiratory infection (ARI). A subset of patients is swabbed and tested by reference laboratories, producing pathogen-specific positivity rates for flu, SARS-CoV-2 and RSV.

Why this source

Combining consultation incidence with virological positivity yields a pathogen-specific weekly incidence signal (ILI × positivity / 100). This is the standard European methodology and provides a more robust view than either indicator alone: consultation rates capture illness burden, positivity confirms which pathogen is driving it.

Qualitative classification

The “low”, “moderate” and “high” categories follow seasonal reference values and epidemiological thresholds calibrated to match our classifications for other countries. The ILI × positivity / 100 product is scaled to comparable thresholds using a divisor of 3, which aligns European sentinel peaks with the consultation-equivalent scale used elsewhere. Data refreshes weekly when ECDC publishes the latest ERVISS update, typically on Thursdays.

Source and seasonal pattern by pathogen

Influenza
The classification is based on the ECDC ERVISS weekly reports, drawing on data from Statens Serum Institut (SSI) via sentinel primary-care surveillance, wastewater monitoring and genomic sequencing. Seasonally, infection waves in Denmark typically peak between January and March; activity is usually markedly lower during the summer months.
COVID-19
The classification is based on the ECDC ERVISS weekly reports, drawing on COVID-19 surveillance data from Statens Serum Institut (SSI) via sentinel primary-care surveillance, wastewater monitoring and genomic sequencing. Seasonally, infection waves in Denmark typically peak during winter, with occasional summer waves driven by new variants; activity is usually markedly lower in late spring between waves.
RSV
The classification is based on the ECDC ERVISS weekly reports, drawing on RSV surveillance data from Statens Serum Institut (SSI) via sentinel primary-care surveillance, wastewater monitoring and genomic sequencing. Seasonally, infection waves in Denmark typically peak between December and February; activity is usually markedly lower in spring and summer.

Frequently asked questions

When is flu season in Denmark?

Danish flu seasons typically build through December, peak between January and March, and fade by April. The exact window shifts each year with the dominant influenza subtypes and residual population immunity. Statens Serum Institut (SSI) describes the season in qualitative phases through its weekly Ugentlige Overvågningsrapporter rather than precise onset dates, and Denmark's Nordic latitude means peaks often arrive slightly later than in central Europe.

How does Statens Serum Institut classify flu severity?

Statens Serum Institut uses qualitative tiers (low, medium, high, very high) derived from historical reference ranges for sentinel consultations, laboratory positivity, and hospital indicators. These tiers reflect whether the week's pressure is ordinary, elevated, or exceptional for the season. SSI also transmits Denmark's indicators to ECDC for inclusion in ERVISS, where Danish classifications sit alongside other EU/EEA countries with the same methodology.

How is flu surveillance organised in Denmark?

Denmark's flu surveillance combines a sentinel network of general practitioners reporting influenza-like illness, a dense virological testing programme coordinated by Statens Serum Institut, and hospital-admission data for severe acute respiratory infection. Denmark has one of the most comprehensive virological surveillance programmes in Europe, with extensive sequencing of respiratory samples. Weekly bulletins summarise the picture and feed ECDC ERVISS.

Is the flu vaccine free in Denmark?

Denmark offers free seasonal flu vaccination each autumn to priority groups including adults aged 65 and above, pregnant women, people with chronic conditions, and healthcare workers, administered through GPs and participating pharmacies. Statens Serum Institut publishes vaccination-coverage estimates alongside its weekly flu surveillance reports. Uptake in Danish older-adult groups is historically among the higher ranges in the EU.

How does Denmark compare to other Nordic countries?

Because Denmark reports into ECDC ERVISS with harmonised indicators, its weekly flu classification is directly comparable with Sweden, Norway, Finland, and the rest of the EU/EEA. Nordic flu curves typically move broadly in step, with small lead–lag differences driven by school calendars and travel patterns. Denmark often peaks a little earlier than Sweden and Finland, though this varies by season.

More situation reports

ECDC ERVISSECDC DataUpdated: Aug 31, 2026, 11:10
Published by Dominik Martin · Software engineer and data aggregator· Methodology last reviewed: 07 May 2026· Methodology version 1.2

Data last refreshed: Aug 31, 2026, 11:10. Update cadence: weekly.

This page is not medical advice and does not replace consultation with a healthcare professional. For specific symptoms, please contact a medical professional.

About this page

Published by Renderei Martin GmbH, Berlin. No commercial interest in individual health recommendations. The app is optionally monetised via a freemium subscription.

Content is based exclusively on the linked official surveillance publications. Medical statements are curated against the guidance of RKI, ECDC and WHO.

Methodology enquiries: press@infectrisk.com

About this site and its author